Redefining the Future of ALS Treatment

Cortexa Therapeutics is forging a new frontier in ALS and neurodegenerative disease treatment by leveraging AI-driven analysis and cutting-edge scientific research to uncover untapped therapeutic strategies. Our multifaceted drug approach targets the root causes of ALS, with the potential to significantly slow or even halt disease progression. With an urgent focus rapid preclinical development, we are committed to translating breakthrough science into real solutions—because in neurodegenerative diseases, time is everything.

Mission: “At Cortexa Therapeutics, our mission is to pioneer transformative treatments for ALS and other neurodegenerative diseases by targeting the root causes of neuronal hyperexcitability and calcium dysregulation. We are committed to advancing innovative, mechanism-driven therapies—from concept to clinic—with urgency, precision, and purpose.”